ZFN: a rival to CRISPR – Life Sciences Intellectual Property Review
Life Sciences Intellectual Property Review |
ZFN: a rival to CRISPR
Life Sciences Intellectual Property Review While CRISPR gene-editing and the battle over its patents continue to dominate headlines, a lesser known contender is making a name for itself, partly thanks to the drive of one company. “Without a doubt, zinc finger nuclease (ZFN) editing is superior … |
